Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern

We conducted preclinical studies in mice using a yeast-produced SARS-CoV-2 RBD subunit vaccine candidate formulated with aluminum hydroxide (alum) and CpG deoxynucleotides. This formulation is equivalent to the Corbevax(TM) vaccine that recently received emergency use authorization by the Drugs Cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Pollet, Jeroen, Strych, Ulrich, Chen, Wen-Hsiang, Versteeg, Leroy, Keegan, Brian, Zhan, Bin, Wei, Junfei, Liu, Zhuyun, Lee, Jungsoon, Kundu, Rahki, Adhikari, Rakesh, Poveda, Cristina, Jose Villar, Maria, Rani Thimmiraju, Syamala, Lopez, Brianna, Gillespie, Portia M., Ronca, Shannon, Kimata, Jason T., Reers, Martin, Paradkar, Vikram, Hotez, Peter J., Elena Bottazzi, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080055/
https://www.ncbi.nlm.nih.gov/pubmed/35568591
http://dx.doi.org/10.1016/j.vaccine.2022.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080055/
https://www.ncbi.nlm.nih.gov/pubmed/35568591
http://dx.doi.org/10.1016/j.vaccine.2022.05.007

Ejemplares similares